• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发并验证一种列线图模型,以预测非高发地区上消化道癌前病变的风险。

Development and external validation of a nomogram to predict the risk of Upper gastrointestinal precancerous lesions in a non-high-incidence area.

机构信息

The Department of Cancer Prevention and Control, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

Department of Pathology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

出版信息

Cancer Med. 2020 Nov;9(22):8722-8732. doi: 10.1002/cam4.3462. Epub 2020 Sep 16.

DOI:10.1002/cam4.3462
PMID:32937009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7666758/
Abstract

BACKGROUND

Upper gastrointestinal precancerous lesions (UGPL) is the major preventable disease in non-high-incidence area. A prognostic nomogram was constructed to predict and identity susceptible population of UGPL before endoscope screening.

METHODS

We recruited 300 ,016 eligible participants for upper gastrointestinal cancer (UGC) screening aged 40-74 years from two cities in Hunan province from 2012 to 2019. Individuals at high risk of UGC on basis of questionnaire estimation underwent endoscopic screening. Participants in two cities accepting endoscopy were used as training and external validation cohorts, respectively. A nomogram was developed based on independent prognostic factors of UGPL determined in multivariable logistic regression analysis.

RESULTS

Of 35, 621 with high risk for UGC, 10, 364 subjects undertook endoscopy (participation rate of 29.1%). The detection rate for UGPL was 4.55%. The nomogram showed that age, gender, mental trama, picked food, and atrophic gastritis history in a descending order were significant contributors to UGPL risk. The C-index value of internal and external validation of the model is 0.612 and 0.670, respectively. The calibration data for UGPL showed optimal agreement between the nomogram prediction and actual observation. Furthermore, high-risk and low-risk group divided based on score from the nomogram predicted a significantly distinct detection rate.

CONCLUSION

The nomogram provides screening workers a simple and accurate tool for identifying individuals at a higher risk of UGPL as primary screening before endoscopy among Chinese population in non-high-risk areas, thus reducing the incidence of UGC by improving the UGPL detection.

摘要

背景

上消化道癌前病变(UGPL)是高发地区以外主要的可预防疾病。本研究构建了一个预测和识别上消化道内镜筛查前高危人群的列线图。

方法

我们招募了 2012 年至 2019 年湖南省两个城市年龄在 40-74 岁的 300016 名上消化道癌(UGC)筛查合格参与者。根据问卷调查估计,UGC 高危人群接受内镜筛查。两个城市接受内镜检查的参与者分别作为训练和外部验证队列。基于多变量逻辑回归分析确定的 UGPL 独立预后因素,建立了一个列线图。

结果

在 35621 名 UGC 高危人群中,有 10364 名接受了内镜检查(参与率为 29.1%)。UGPL 的检出率为 4.55%。列线图显示,年龄、性别、精神创伤、挑食和萎缩性胃炎史依次是 UGPL 风险的重要因素。模型内部和外部验证的 C 指数值分别为 0.612 和 0.670。UGPL 的校准数据显示,列线图预测与实际观察之间具有最佳一致性。此外,根据列线图评分将高危和低危组进行分组,可以预测出显著不同的检出率。

结论

该列线图为筛查工作人员提供了一种简单而准确的工具,可用于识别中国非高危地区人群在上消化道内镜筛查前 UGPL 风险较高的个体,从而通过提高 UGPL 的检出率来降低 UGC 的发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da4/7666758/92315268e190/CAM4-9-8722-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da4/7666758/82aac94e11ac/CAM4-9-8722-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da4/7666758/773aed9d50a2/CAM4-9-8722-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da4/7666758/b65bc457d423/CAM4-9-8722-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da4/7666758/92315268e190/CAM4-9-8722-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da4/7666758/82aac94e11ac/CAM4-9-8722-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da4/7666758/773aed9d50a2/CAM4-9-8722-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da4/7666758/b65bc457d423/CAM4-9-8722-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da4/7666758/92315268e190/CAM4-9-8722-g004.jpg

相似文献

1
Development and external validation of a nomogram to predict the risk of Upper gastrointestinal precancerous lesions in a non-high-incidence area.开发并验证一种列线图模型,以预测非高发地区上消化道癌前病变的风险。
Cancer Med. 2020 Nov;9(22):8722-8732. doi: 10.1002/cam4.3462. Epub 2020 Sep 16.
2
Community-Based Upper Gastrointestinal Cancer Screening in a Randomized Controlled Trial: Baseline Results in a Non-high-incidence Area.基于社区的上消化道癌筛查的随机对照试验:非高发地区的基线结果。
Cancer Prev Res (Phila). 2020 Mar;13(3):317-328. doi: 10.1158/1940-6207.CAPR-19-0422. Epub 2019 Dec 23.
3
Outcomes of upper gastrointestinal cancer screening in high-risk individuals: a population-based prospective study in Northeast China.高危人群上消化道癌筛查的结果:中国东北地区一项基于人群的前瞻性研究。
BMJ Open. 2022 Feb 15;12(2):e046134. doi: 10.1136/bmjopen-2020-046134.
4
Development of a prognostic nomogram for cirrhotic patients with upper gastrointestinal bleeding.肝硬化合并上消化道出血患者预后列线图的开发
Eur J Gastroenterol Hepatol. 2017 Oct;29(10):1166-1173. doi: 10.1097/MEG.0000000000000943.
5
Effectiveness of Risk-Adapted Upper Gastrointestinal Cancer Screening in China: Prospective Cohort Study.中国风险适应型上消化道癌筛查的效果:前瞻性队列研究。
JMIR Public Health Surveill. 2024 Oct 10;10:e62864. doi: 10.2196/62864.
6
[Screening results and influencing factors of upper gastrointestinal carcinoma and precancerous lesions in Feicheng City].[肥城市上消化道癌及癌前病变筛查结果与影响因素]
Zhonghua Zhong Liu Za Zhi. 2018 May 23;40(5):396-399. doi: 10.3760/cma.j.issn.0253-3766.2018.05.014.
7
Development and validation of a nomogram to better predict hypertension based on a 10-year retrospective cohort study in China.基于中国一项10年回顾性队列研究的高血压预测列线图的开发与验证
Elife. 2021 May 28;10:e66419. doi: 10.7554/eLife.66419.
8
Determinants of participation and detection rate of upper gastrointestinal cancer from population-based screening program in China.中国基于人群的上消化道癌筛查项目中参与者比例和检出率的决定因素。
Cancer Med. 2019 Nov;8(16):7098-7107. doi: 10.1002/cam4.2578. Epub 2019 Sep 27.
9
Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma.列名细胞癌患者生存风险预测列线图的开发与验证。
Biosci Rep. 2020 Aug 28;40(8). doi: 10.1042/BSR20200228.
10
A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.基于 SEER 的列线图能准确预测尤文肉瘤的预后。
Sci Rep. 2021 Nov 22;11(1):22723. doi: 10.1038/s41598-021-02134-0.

引用本文的文献

1
Development and validation of a nomogram for obesity and related factors to detect gastric precancerous lesions in the Chinese population: a retrospective cohort study.中国人群中用于检测胃癌前病变的肥胖及相关因素列线图的开发与验证:一项回顾性队列研究
Front Oncol. 2024 Nov 20;14:1419845. doi: 10.3389/fonc.2024.1419845. eCollection 2024.

本文引用的文献

1
Global Burden of 5 Major Types of Gastrointestinal Cancer.全球 5 大常见胃肠道癌症负担
Gastroenterology. 2020 Jul;159(1):335-349.e15. doi: 10.1053/j.gastro.2020.02.068. Epub 2020 Apr 2.
2
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.在现代化疗时代,列线图修订风险指数的验证及其与其他模型在结外鼻型 NK/T 细胞淋巴瘤中的比较:预后和临床决策的指征。
Leukemia. 2021 Jan;35(1):130-142. doi: 10.1038/s41375-020-0791-3. Epub 2020 Mar 9.
3
Community-Based Upper Gastrointestinal Cancer Screening in a Randomized Controlled Trial: Baseline Results in a Non-high-incidence Area.
基于社区的上消化道癌筛查的随机对照试验:非高发地区的基线结果。
Cancer Prev Res (Phila). 2020 Mar;13(3):317-328. doi: 10.1158/1940-6207.CAPR-19-0422. Epub 2019 Dec 23.
4
Development and validation of a prognostic nomogram for predicting post-operative pulmonary infection in gastric cancer patients following radical gastrectomy.开发和验证用于预测根治性胃切除术后胃癌患者术后肺部感染的预后列线图。
Sci Rep. 2019 Oct 10;9(1):14587. doi: 10.1038/s41598-019-51227-4.
5
Determinants of participation and detection rate of upper gastrointestinal cancer from population-based screening program in China.中国基于人群的上消化道癌筛查项目中参与者比例和检出率的决定因素。
Cancer Med. 2019 Nov;8(16):7098-7107. doi: 10.1002/cam4.2578. Epub 2019 Sep 27.
6
Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study.开发和验证一种用于估计中国高危人群胃癌风险的预测规则:一项全国性多中心研究。
Gut. 2019 Sep;68(9):1576-1587. doi: 10.1136/gutjnl-2018-317556. Epub 2019 Mar 29.
7
Effectiveness of Intensive Endoscopic Screening for Esophageal Cancer in China: A Community-Based Study.中国强化内镜筛查食管癌的效果:一项基于社区的研究。
Am J Epidemiol. 2019 Apr 1;188(4):776-784. doi: 10.1093/aje/kwy291.
8
Risk factors for oesophageal cancer.食管癌的危险因素。
Best Pract Res Clin Gastroenterol. 2018 Oct-Dec;36-37:3-8. doi: 10.1016/j.bpg.2018.11.008. Epub 2018 Nov 22.
9
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
10
[Screening results and influencing factors of upper gastrointestinal carcinoma and precancerous lesions in Feicheng City].[肥城市上消化道癌及癌前病变筛查结果与影响因素]
Zhonghua Zhong Liu Za Zhi. 2018 May 23;40(5):396-399. doi: 10.3760/cma.j.issn.0253-3766.2018.05.014.